Skip to content

U-100 unit conversion

Thymosin Alpha-1 calculator

Convert mass and volume to U-100 units. No dose is selected.

These are example numbers so you can see the math. Try yours. Change them to match the vial in your hand.

10U-100 units · 0.1 mL

25 mcg per unit · 2500 mcg/mL

How the calculator works, sources and review dates

Thymosin Alpha-1 math uses the listed vial sizes on this card and the liquid you type. Concentration in mcg per mL is vial milligrams times 1000, divided by milliliters. A U-100 syringe has 100 marks per milliliter, so each unit is that concentration divided by 100. Example numbers so you can see the math: a 5 mg listing plus 2 mL of liquid. Change any number and the units change. Try the numbers. A research-market vial is not the same material used in a trial.

Editorial review 2026-10-09. source-curated; clinician review pending.

Units chart for listed Thymosin Alpha-1 sizes

U-100 math for listed Thymosin Alpha-1 sizes. Each cell is micrograms per syringe mark if you add that much liquid. The table does the same math as the calculator. It does not pick an amount for you.

Micrograms per U-100 unit (100 marks / mL)
Listed vial1 mL liquid2 mL liquid3 mL liquid
5 mg502516.7
10 mg1005033.3

What is Thymosin Alpha-1?

Other names in the library: thymalfasin, ta1, Thymosin Alpha 1 (10MG), Thymosin Alpha-1 — 10mg / Premium, Thymosin Alpha-1 — 5mg / Premium. The cited evidence and any approval concern the studied or labeled preparation. Oral, nasal, cosmetic and research-market versions do not inherit product approval or proven efficacy. Listed sizes: 5 mg, 10 mg. A seller title is a listing. It does not prove the vial matches a paper.

What the evidence says

For each trial, check who or what was studied, which preparation was used and what the findings support before comparing it with personal reports about individual experiences or seller listings that describe a product but don’t establish that it works.

Human trial

The efficacy and safety of thymosin α1 for sepsis (TESTS): multicentre, double blinded, randomised, placebo controlled, phase 3 trial.

1106 randomized sepsis patients, 22 Chinese centers

Reported findings. No overall mortality advantage

Nonresponse. Corrected 28-day HR0.97 (CI0.76-1.24), P0.82; 90-day HR0.95 (CI0.77-1.17), P0.61. No clear mortality benefit in studied sepsis population.

Harms. No significant safety difference; linked erratum needs reconciliation

Limits. Correction recovered survival data for9 participants and changed lymphocyte data for35/1106 and data-sharing statement. Cached abstracts may retain outdated estimates; use linked correction.

Preparation: Thymosin alpha-1 trial preparation Route: subcutaneous

Read original source ↗

Editorial review 2026-10-09. Clinician review pending.

Regulatory status, dated 2026-10-09

FDA product approval

not approved. No US therapeutic product approval is established by this curated source set; other countries and products may differ.

Compounding

not established. Compounded products do not carry FDA product approval; legal eligibility is not established here.

Research

investigational. Evidence varies by illness and country; general immune or longevity benefit is not established.

Sport

unknown. Not individually verified; consult the current sport rules. Absence of a listing is not permission.

How long it lasts, how you store it, listed sizes

This entry doesn’t give a duration in hours. No verified formulation-specific human estimate in this source set; no guessed value is supplied.

Half-life on file: no single hour value. No verified formulation-specific human estimate in this source set; no guessed value is supplied. Follow the label on the vial you hold. This page does not set a throw-away date after you add water.

Risks and mix-ups already on the record

  • Safety is incomplete; absence of reports does not establish safety.
  • Unknown or incomplete for research formulations; this is not a clearance for use.
  • Unknown or incomplete; do not infer compatibility with medications or other substances.

People using PepBear often log: Existing clinician-directed records, symptoms and dated health measurements. Record missing data; trends do not demonstrate causation.

Sources

  1. Primary evidence or regulator source · checked 2026-10-09

Questions people ask

Is Thymosin Alpha-1 FDA-approved?

not approved. No US therapeutic product approval is established by this curated source set; other countries and products may differ.

Does PepBear pick an amount of Thymosin Alpha-1?

The calculator turns numbers you type into U-100 units. Trial or label amounts stay as cited facts.

How many units is a listed Thymosin Alpha-1 vial after you add water?

Units = (amount in mcg ÷ (vial mg × 1000 ÷ water mL)) × 100 on a U-100 syringe. Enter the three numbers. The chart shows the same math for each listed vial size and 1, 2 or 3 mL of liquid.

Why flag amounts under 5 units?

A U-100 barrel is easy to misread below about 5 marks. That is a measuring warning. The page does not tell you to take more.

Related cards

A licensed clinician must interpret the evidence for your situation. This entry provides education, not treatment instructions. Not medical advice. PepBear does not pick a dose, a cycle, or a seller.